Related Experiment Video
Updated: Jun 29, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles
Maria Letizia Manca1, Giuseppe Loy, Marco Zaru
1Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece.
Abstract:
Recently three groups of rifampicin (RIF)-loaded microparticles (MPs), consisting of chitosan (CHT), PLGA and PLGA/CHT mixtures, were assessed in terms of RIF-loading and retention during nebulisation. The CHT-coated PLGA MPs were found to exhibit high RIF-loading ability together with nebulisation ability, stability, and mucoadhesive properties. All MP types had comparable toxicity towards alveolar cells which was significantly lower than that of the free drug. Herein, we study the release of RIF from all MP-types, during incubation in buffer with pH values: 4.40 and 7.40. Results show that CHT particles exhibit a higher burst release compared to PLGA MPs; at pH 4.40, which is explained by the higher solubility of CHT in acidic media. At pH 7.40 burst release from CHT MP's is significantly lower when CHT is crosslinked with glutaraldehyde, which is consistent with their - previously observed - increased stability during nebulization. From PLGA MPs, RIF release was pH independent under the conditions applied, while the amount of PVA (stabilizer) considerably affected drug release. When PLGA MP's were coated with CHT, at pH 7.40 the retention of RIF increased further (compared to non-coated MPs), while at pH 4.40 the release was faster from the CHT-coated particles. Concluding, it is proven that when PLGA MPs are coated with CHT, in addition to increased particle mucoadhesive properties, the release kinetics of RIF are modified.
Insights
Chitosan-coated PLGA microparticles enhance rifampicin loading and mucoadhesion for nebulization. Coating modifies drug release kinetics, offering potential for improved pulmonary drug delivery.
Area of Science:
- Materials Science
- Pharmaceutical Sciences
- Biotechnology
Background:
- Rifampicin (RIF) delivery via microparticles (MPs) is explored for pulmonary applications.
- Chitosan (CHT), PLGA, and CHT/PLGA mixtures were investigated for RIF-loaded MPs.
- CHT-coated PLGA MPs demonstrated superior RIF-loading, nebulization, stability, and mucoadhesion.
Purpose of the Study:
- To investigate the release kinetics of RIF from CHT, PLGA, and CHT/PLGA MPs.
- To evaluate the influence of pH (4.40 and 7.40) on RIF release.
- To assess the impact of CHT coating on PLGA MP drug release.
Main Methods:
- Preparation and characterization of RIF-loaded MPs (CHT, PLGA, PLGA/CHT).
- In vitro drug release studies in buffers at pH 4.40 and 7.40.
- Assessment of RIF release profiles and kinetics.
Main Results:
- CHT MPs showed higher burst release at pH 4.40 due to CHT solubility.
- Crosslinking CHT with glutaraldehyde reduced burst release at pH 7.40.
- RIF release from PLGA MPs was pH-independent, influenced by PVA stabilizer.
- CHT coating on PLGA MPs increased RIF retention at pH 7.40 but accelerated release at pH 4.40.
Conclusions:
- PLGA MPs coated with CHT exhibit modified RIF release kinetics.
- CHT coating enhances mucoadhesive properties of PLGA MPs.
- These findings suggest potential for optimized pulmonary drug delivery systems.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Influencing Factors

